| NCT ID | NCT06064136 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Condition | Hip Injuries |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2025-12 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2025-12 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The ilio-psoas conflict is a commonly accepted complication after total hip replacement, often linked to a mispositioning of the acetabular prosthetic component that conflicts with the ilio-psoas tendon. To correct these pains, a psoas tenotomy can be proposed. The results proven by the literature are very satisfactory. Psoas tenotomy is performed endoscopically, arthroscopically, or more rarely open. The contribution of echo surgery allows to limit the scar ransom but also to free itself from a complex infrastructure to the operating room including an arthroscopy column and an intraoperative fluoroscopy for a conventional tenotomy, This also saves procedural and installation time. No studies to date have described ultrasound-assisted psoas tenotomy Yhe investigators conducted a cadaveric study of the feasibility of psoas tenotomy under ultrasound that confirms the feasibility of this technique and the safety of the gesture for the surrounding anatomical structures. The objectives of this study are to assess the feasibility, pain and functional outcomes of ultrasound-assisted psoas tenotomy in patients with ilio-psoas conflict after total hip replacement.
Eligibility Criteria
Inclusion criteria: * Patients 18 years of age or older * Indication of psoas tenotomy for ilio-psoas conflict after total hip replacement * Signature of the written informed consent form by the patient * Affiliation to a French health insurance scheme or equivalent Non Inclusion criteria: * Vulnerable people: pregnant or breast-feeding women (patients will undergo a pregnancy test: urinary test), adult under guardianship or deprived of freedom. * Allergies to local anesthetics * Patient on anticoagulant or antiplatelet agents * Contraindication to surgery * Refusal of patient involvement
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06064136 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hip Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06064136 currently recruiting?
Yes, NCT06064136 is actively recruiting participants. Contact the research team at micicoi.g@chu-nice.fr for enrollment information.
Where is the NCT06064136 trial being conducted?
This trial is being conducted at Nice, France.
Who is sponsoring the NCT06064136 clinical trial?
NCT06064136 is sponsored by Centre Hospitalier Universitaire de Nice. The trial plans to enroll 15 participants.